Multiple Sclerosis News Today Forums › Forums › Treating MS › MS Medications › Study reports its OK to lengthen Tysabri treatment schedule

  • MS Medications

    Study reports its OK to lengthen Tysabri treatment schedule

    Posted by ed-tobias on October 30, 2023 at 6:00 am
    Recent research reports lengthening the gap between Tysabri treatments, from every four weeks reduces the risk of the brain disease PML without lowering efficacy of the DMT.

    Have you been treated with Tysabri? What is your treatment gap and are you concerned about PML risk?
    replied 6 months, 2 weeks ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .